Relevium Technologies Inc (CVE:RLV) Focus On Pediatric Applications for Cannabinoids


Relevium Technologies Inc.(CVE:RLV) (OTCMKTS:RLLVF) (FRA:6BX) CEO Aurelio Useche joins Midas Letter to introduce the company. Relevium is a publicly traded corporation strategically focused on the expansion and acquisition of entrepreneurial brands within the health and wellness sector. Their focus is on being a trusted source of high-quality nutraceutical and CBD products, specifically under three verticals: Pain Relief, Recovery, and Performance. With operations in Colombia, Aurelio discusses the company’s operations and future plans including a joint venture with an Italian company for their first commercial grow. Aurelio elaborates on Relevium Technologies products and the pediatric applications for cannabinoids. He looks to the future and divulges the drivers of success for 2020.


#Nutrition #Nutraceutical #Supplements #SportsNutrition #Cosmoceuticals #Cannabis #CBD #MedicalCannabis #ACMPR #Hemp #HempProducts #CannabisProducts #HealthandWellness #HolisticMedicine #HealthyLifestyles #InvestinginHealth #InvestinginCannabis #InvestinginHealth #InvestinginCannabis #InvestinginHemp #PotStocks #Cannabiz #HempStocks #InvestinginCBD #SmallCapStocks #FrontierMCG


SOURCE

Recent Posts

See All

Toronto | Montreal | Calgary | Vancouver

https://www.frontiermcg.com